APA (7th ed.) Citation

Elgendy, I. Y., Mahmoud, A. N., Barakat, A. F., Elgendy, A. Y., Saad, M., Abuzaid, A., . . . Bavry, A. A. (2017). Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions, 17(2), 143-155. https://doi.org/10.1007/s40256-016-0208-x

Chicago Style (17th ed.) Citation

Elgendy, Islam Y., Ahmed N. Mahmoud, Amr F. Barakat, Akram Y. Elgendy, Marwan Saad, Ahmed Abuzaid, Siddarth A. Wayangankar, and Anthony A. Bavry. "Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 17, no. 2 (2017): 143-155. https://doi.org/10.1007/s40256-016-0208-x.

MLA (9th ed.) Citation

Elgendy, Islam Y., et al. "Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 17, no. 2, 2017, pp. 143-155, https://doi.org/10.1007/s40256-016-0208-x.